Neural circuits are interconnected networks of neurons that work together to process information and control brain functions. In neurodegenerative diseases, circuit dysfunction is a hallmark feature that leads to characteristic cognitive and motor deficits. Understanding which circuits are affected, how pathology spreads along them, and how to restore their function is central to developing effective therapies.
Neural circuits in the brain form the structural and functional basis for all cognitive, motor, and autonomic processes. In neurodegenerative diseases like Alzheimer's and Parkinson's, specific neural circuits become vulnerable to pathological changes, leading to the characteristic symptoms of each disorder[1]. This vulnerability is determined by factors including:
| Disease | Primary Affected Circuits | Key Symptoms |
|---|---|---|
| Alzheimer's Disease | Hippocampal-entorhinal circuits | Memory impairment |
| Parkinson's Disease | Basal ganglia motor circuits | Movement deficits |
| Frontotemporal Dementia | Frontal/temporal circuits | Behavioral/language changes |
| Huntington's Disease | Striatal-cortical circuits | Motor + cognitive decline |
| ALS | Corticospinal circuits | Motor weakness |
The hippocampal formation is critical for memory formation and consolidation[2]. The canonical circuit involves:
This trisynaptic circuit (EC → DG → CA3 → CA1) is the foundation of episodic memory formation[@memory circuits].
Alzheimer's disease progressively disrupts hippocampal circuits:
Early Stage:
Intermediate Stage:
Late Stage:
Several molecular mechanisms link amyloid and tau pathology to circuit dysfunction:
The default mode network (DMN) is specifically vulnerable in Alzheimer's disease[@default mode]. This network includes:
DMN dysfunction correlates with amyloid deposition and predicts cognitive decline.
The basal ganglia form parallel loops processing motor, oculomotor, associative, and limbic information[@basal ganglia]. The motor circuit specifically includes:
Cortex (motor areas)
↓
Striatum (caudate + putamen)
↓
Internal segment of Globus Pallidus (GPi)
Substantia Nigra pars reticulata (SNr)
↓
Thalamus
↓
Motor Cortex
This direct pathway facilitates movement, while the indirect pathway inhibits competing movements.
In Parkinson's disease, dopaminergic neuron loss in the substantia nigra pars compacta (SNc) disrupts basal ganglia function:
| Pathway | Normal Function | Parkinson's State |
|---|---|---|
| Direct (D1) | Facilitate movement | Reduced activity |
| Indirect (D2) | Inhibit competing movements | Increased activity |
| Hyperdirect | Rapid movement inhibition | Normal |
Deep brain stimulation (DBS) effectively treats Parkinson's disease by modulating basal ganglia circuits[@dbs parkinson]. Key targets include:
DBS works by:
Frontotemporal dementia primarily affects frontal and anterior temporal circuits[@cortical circuits]. Key circuits include:
The behavioral variant FTD involves:
A key insight in neurodegeneration research is that pathological proteins spread along neural circuits in a predictable pattern[@tau spread][@alpha synuclein spread]:
Synaptic Transmission: Pathological proteins transmitted across synapses
Trophic Support Loss: Disconnection from target neurons → secondary degeneration
Network Inhibition: Dysfunction in one area inhibits connected regions
Activity-Dependent Spread: Active circuits may facilitate transmission
Circuit-based propagation has important therapeutic implications:
Understanding circuit-level changes enables therapeutic development[@circuit repair]:
Microglia and other immune cells modulate circuit function[3]:
The hippocampus maintains adult neurogenesis[@neurogenesis circuits]:
Key circuits are conserved across species:
This conservation enables translational research from animal models.
Circuit dysfunction can be measured non-invasively:
These biomarkers enable:
Palop JJ, et al. Neural circuits in neurodegeneration - mechanisms and therapeutics. Nature Reviews Neurology. 2024. ↩︎
Palop JJ, Mucke L. Hippocampal circuit dysfunction in Alzheimer's disease. Nature Reviews Neuroscience. 2016. ↩︎
Prinz M, et al. Neuroimmune crosstalk in neural circuits. Nature Reviews Neuroscience. 2021. ↩︎